Evaluation of Budesonide/Formoterol SPIROMAX® Versus SYMBICORT® TURBOHALER®

Study Title

Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAXֲ® Inhalation Powder Versus SYMBICORTֲ® TURBOHALERֲ®

Teva Identifier

BFS-AS-306 | 2013-000081-11

ClinicalTrials.gov Identifier

NCT01803555

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Budesonide/Formoterol SPIROMAXֲ® | Drug: SYMBICORTֲ® TURBOHALERֲ®

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

06/01/2013 - 07/01/2014

Phase

Phase 3

Study Type

Interventional